Search Results 1521-1530 of 18136 for monoclonal antibody
Complement activation after binding of an IgG autoantibody ... monoclonal IgG that neutralises the complement protein C5--in neuromyelitis optica spectrum ...
The purpose of this study is to evaluate the clinical and neurocognitive correlates of COVID-19 in patients with bipolar disorder (BD). Participation ...
This is a Phase 2, multicenter, proof-of-concept platform study in adult participants with moderately to severely active ulcerative colitis (UC). The primary ...
The purpose of this study is to identify novel anti neuronal antibodies that contribute to autoimmune gastrointestinal motility disorders by analyzing the serum ...
Adalimumab-aacf injection is used to treat the symptoms and prevent the progression of moderate to severe rheumatoid arthritis and ankylosing spondylitis. It is ...
— Mayo Clinic researchers have validated a new antibody test to diagnose multiple sclerosis (MS), a potentially disabling disease of the brain and spinal cord.
... antibody, doxycycline for amyloid, or other investigational treatment directed at amyloid. Waldenström's macroglobulinemia and/or immunoglobulin M monoclonal ...
Strategies for immunization and antibody screening and production. Type, form and amount of antigen(s) to be used. Timetable for immunization, fusion and ...
About this study. This is a multi-center, Phase 2 trial of ublituximab as first-line combination therapy in early, active autoantibody positive ...
The primary objective of this study is to assess the effectiveness of fostamatinib in subjects with warm antibody autoimmune hemolytic anemia (wAIHA).
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift doubles in impact to help more patients.